Cargando…

The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing

BACKGROUND: In diagnostic evaluation, it is necessary to assess the clinical impact of a new diagnostic as well as its diagnostic accuracy. The comparative interrupted time series design has been proposed as a quasi-experimental approach to evaluating interventions. We show how it can be used in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanshawe, Thomas R., Turner, Philip J., Gillespie, Marjorie M., Hayward, Gail N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888027/
https://www.ncbi.nlm.nih.gov/pubmed/35232491
http://dx.doi.org/10.1186/s41512-022-00118-w
_version_ 1784661032811102208
author Fanshawe, Thomas R.
Turner, Philip J.
Gillespie, Marjorie M.
Hayward, Gail N.
author_facet Fanshawe, Thomas R.
Turner, Philip J.
Gillespie, Marjorie M.
Hayward, Gail N.
author_sort Fanshawe, Thomas R.
collection PubMed
description BACKGROUND: In diagnostic evaluation, it is necessary to assess the clinical impact of a new diagnostic as well as its diagnostic accuracy. The comparative interrupted time series design has been proposed as a quasi-experimental approach to evaluating interventions. We show how it can be used in the design of a study to evaluate a point-of-care diagnostic test for C-reactive protein in out-of-hours primary care services, to guide antibiotic prescribing among patients presenting with possible respiratory tract infection. This study consisted of a retrospective phase that used routinely collected monthly antibiotic prescribing data from different study sites, and a prospective phase in which antibiotic prescribing rates were monitored after the C-reactive protein diagnostic was introduced at some of the sites. METHODS: Of 8 study sites, 3 were assigned to receive the diagnostic and 5 were assigned as controls. We obtained retrospective monthly time series of respiratory tract targeted antibiotic prescriptions at each site. Separate ARIMA models at each site were used these to forecast monthly prescription counts that would be expected in the prospective phase, using simulation to obtain a set of 1-year predictions alongside their standard errors. We show how these forecasts can be combined to test for a change in prescription rates after introduction of the diagnostic and estimate power to detect this change. RESULTS: Fitted time series models at each site were stationary and showed second-order annual seasonality, with a clear December peak in prescriptions, although the timing and extent of the peak varied between sites and between years. Mean one-year predictions of antibiotic prescribing rates based on the retrospective time series analysis differed between sites assigned to receive the diagnostic and those assigned to control. Adjusting for the trend in the retrospective time series at each site removed these differences. CONCLUSIONS: Quasi-experimental designs such as comparative interrupted time series can be used in diagnostic evaluation to estimate effect sizes before conducting a full randomised controlled trial or if a randomised trial is infeasible. In multi-site studies, existing retrospective data should be used to adjust for underlying differences between sites to make outcome data from different sites comparable, when possible. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41512-022-00118-w.
format Online
Article
Text
id pubmed-8888027
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88880272022-03-02 The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing Fanshawe, Thomas R. Turner, Philip J. Gillespie, Marjorie M. Hayward, Gail N. Diagn Progn Res Methodology BACKGROUND: In diagnostic evaluation, it is necessary to assess the clinical impact of a new diagnostic as well as its diagnostic accuracy. The comparative interrupted time series design has been proposed as a quasi-experimental approach to evaluating interventions. We show how it can be used in the design of a study to evaluate a point-of-care diagnostic test for C-reactive protein in out-of-hours primary care services, to guide antibiotic prescribing among patients presenting with possible respiratory tract infection. This study consisted of a retrospective phase that used routinely collected monthly antibiotic prescribing data from different study sites, and a prospective phase in which antibiotic prescribing rates were monitored after the C-reactive protein diagnostic was introduced at some of the sites. METHODS: Of 8 study sites, 3 were assigned to receive the diagnostic and 5 were assigned as controls. We obtained retrospective monthly time series of respiratory tract targeted antibiotic prescriptions at each site. Separate ARIMA models at each site were used these to forecast monthly prescription counts that would be expected in the prospective phase, using simulation to obtain a set of 1-year predictions alongside their standard errors. We show how these forecasts can be combined to test for a change in prescription rates after introduction of the diagnostic and estimate power to detect this change. RESULTS: Fitted time series models at each site were stationary and showed second-order annual seasonality, with a clear December peak in prescriptions, although the timing and extent of the peak varied between sites and between years. Mean one-year predictions of antibiotic prescribing rates based on the retrospective time series analysis differed between sites assigned to receive the diagnostic and those assigned to control. Adjusting for the trend in the retrospective time series at each site removed these differences. CONCLUSIONS: Quasi-experimental designs such as comparative interrupted time series can be used in diagnostic evaluation to estimate effect sizes before conducting a full randomised controlled trial or if a randomised trial is infeasible. In multi-site studies, existing retrospective data should be used to adjust for underlying differences between sites to make outcome data from different sites comparable, when possible. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41512-022-00118-w. BioMed Central 2022-03-02 /pmc/articles/PMC8888027/ /pubmed/35232491 http://dx.doi.org/10.1186/s41512-022-00118-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Methodology
Fanshawe, Thomas R.
Turner, Philip J.
Gillespie, Marjorie M.
Hayward, Gail N.
The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing
title The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing
title_full The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing
title_fullStr The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing
title_full_unstemmed The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing
title_short The comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care C-reactive protein testing
title_sort comparative interrupted time series design for assessment of diagnostic impact: methodological considerations and an example using point-of-care c-reactive protein testing
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888027/
https://www.ncbi.nlm.nih.gov/pubmed/35232491
http://dx.doi.org/10.1186/s41512-022-00118-w
work_keys_str_mv AT fanshawethomasr thecomparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting
AT turnerphilipj thecomparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting
AT gillespiemarjoriem thecomparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting
AT haywardgailn thecomparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting
AT fanshawethomasr comparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting
AT turnerphilipj comparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting
AT gillespiemarjoriem comparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting
AT haywardgailn comparativeinterruptedtimeseriesdesignforassessmentofdiagnosticimpactmethodologicalconsiderationsandanexampleusingpointofcarecreactiveproteintesting